• Latest Posts

PacBio and Boston Children’s Hospital to study genome to benefit patients

Rani Therapeutics reveals results from phase 1 osteoporosis study

FDA clears insulin pen medical device

Entact Bio launches with $81M to develop precision medicines

Avalon BioVentures to invest in early-stage biotech

Pictor receives $5M in funding for Covid antibody test and human and animal portfolios

ADVERTISEMENT

Positive results from BioAge muscle atrophy trial 

New company Liminatus Pharma Inc to develop three cancer treatments

MaxCyte and Curamys sign cell and gene therapies agreement

Interview 5 Dec 2022

Interview: why the recently approved fecal microbiome product is causing a rumble

Full-Life Technologies acquiring Focus-X Therapeutics

FDA’s approval of first fecal microbiota product, Rebyota, hailed an ‘enormous step forward’ for the field

ADVERTISEMENT